- Home
- TALK vs KMDA Comparison
TALK vs KMDA Comparison
Compare TALK & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALK
- KMDA
- Stock Information
- Founded
- TALK 2012
- KMDA 1990
- Country
- TALK United States
- KMDA Israel
- Employees
- TALK N/A
- KMDA 374
- Industry
- TALK Medical/Nursing Services
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- TALK Health Care
- KMDA Health Care
- Exchange
- TALK Nasdaq
- KMDA Nasdaq
- Market Cap
- TALK 442.1M
- KMDA 392.2M
- IPO Year
- TALK N/A
- KMDA N/A
- Fundamental
- Price
- TALK $2.76
- KMDA $6.56
- Analyst Decision
- TALK Buy
- KMDA Strong Buy
- Analyst Count
- TALK 6
- KMDA 2
- Target Price
- TALK $4.50
- KMDA $13.00
- AVG Volume (30 Days)
- TALK 1.0M
- KMDA 51.3K
- Earning Date
- TALK 10-28-2025
- KMDA 11-12-2025
- Dividend Yield
- TALK N/A
- KMDA 2.99%
- EPS Growth
- TALK N/A
- KMDA 27.97
- EPS
- TALK 0.02
- KMDA 0.32
- Revenue
- TALK $202,611,000.00
- KMDA $169,517,000.00
- Revenue This Year
- TALK $22.35
- KMDA $14.49
- Revenue Next Year
- TALK $21.66
- KMDA $10.12
- P/E Ratio
- TALK $166.40
- KMDA $20.86
- Revenue Growth
- TALK 17.43
- KMDA 9.67
- 52 Week Low
- TALK $2.22
- KMDA $5.17
- 52 Week High
- TALK $4.36
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- TALK 62.88
- KMDA 40.07
- Support Level
- TALK $2.66
- KMDA $6.76
- Resistance Level
- TALK $2.86
- KMDA $6.89
- Average True Range (ATR)
- TALK 0.11
- KMDA 0.15
- MACD
- TALK 0.02
- KMDA -0.00
- Stochastic Oscillator
- TALK 76.19
- KMDA 30.61
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.